Out-of-pocket costs for branded drugs to treat multiple sclerosis (MS), Alzheimer's, and Parkinson's disease rose from 2012 ...

A definition of Alzheimer's disease -- one that requires objective cognitive deficits in addition to brain amyloid for ...

Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

What is the history behind naming November as National Alzheimer's Disease Awareness Month? After gaining an understanding of ...

In a small early trial using a transcranial magnetic stimulation procedure, scientists were able to target a key brain ...

"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

Researchers from the International Working Group recommend categorizing biomarker-positive, cognitively normal individuals as ...

In healthy brains, immune cells called microglia patrol for damage, clearing away debris and harmful proteins. But in the ...

After some time, early symptomatic Alzheimer's disease begins with a small amount of memory loss and confusion that can be ...

For years, scientists have observed a connection between type 2 diabetes and an increased risk of dementia, particularly ...